Literature DB >> 6618797

Pharmacokinetic interpretation of vitreous fluorophotometry.

R C Zeimer, N P Blair, J G Cunha-Vaz.   

Abstract

Vitreous fluorophotometry is producing an increasing amount of clinical and experimental data. In order to interpret these data and obtain quantitative values for the permeability of the blood ocular barriers, there is a need to understand better the basic phenomena governing the transport of fluorescein. We present here a refined mathematical model that we use to interpret a large body of clinical data yielding values for the inward (6.9 x 10(-6) cm/min) and outward (210 x 10(-6) cm/min) posterior permeability coefficients, the effective diffusion coefficient in the vitreous (8 x 10(-4) cm2/min), and the plasma fluorescein decay constants (1.17, 0.34, and 0.044 per hour). Moreover, we utilize the model to make predictions related to kinetic vitreous fluorophotometry and to the reliability of the procedure to calculate the permeability coefficients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6618797

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Outward permeability of the blood-retinal barrier.

Authors:  A Yoshida; S Ishiko; M Kojima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

2.  Blood-retinal barrier permeability to carboxyfluorescein and fluorescein in monkeys.

Authors:  N P Blair; M M Rusin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

3.  Computer modeling of drug delivery to the posterior eye: effect of active transport and loss to choroidal blood flow.

Authors:  Ram K Balachandran; Victor H Barocas
Journal:  Pharm Res       Date:  2008-08-05       Impact factor: 4.200

4.  Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.

Authors:  H J Van Schaik; B Heintz; M Larsen; E Leite; V Rosas; R Schalnus; J A Van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

5.  Study of fluorescein glucuronide. II. A comparative ocular kinetic study of fluorescein and fluorescein glucuronide.

Authors:  C Seto; M Araie; M Takase
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

6.  Pharmacokinetic interpretation of kinetic vitreous fluorophotometry.

Authors:  R C Zeimer; N P Blair; J G Cunha-Vaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

7.  Passive permeability and outward active transport of fluorescein across the blood-retinal barrier in early ARM.

Authors:  B Moldow; M Larsen; B Sander; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

8.  Vitreous laser absorption following fluorescein angiography in diabetic patients.

Authors:  C Azzolini; S Fantaguzzi; R Brancato; F Docchio; F Bandello; L Guarisco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

9.  Plasma fluorescein and fluorescein glucuronide in patients with selected eye diseases.

Authors:  N P Blair; M A Evans; T S Lesar; M Willett
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.